For U.S. Residents Only
Some restrictions may apply.
Play BPH Video
BPH VIDEO TOUR

This will help explain BPH and why you might be spending more time in the bathroom.
Learn More Arrow

BPH Quiz
DO YOU HAVE BPH

Take this brief quiz to find out. If you're a man age 60+, there is a 50% chance that you have BPH.
Take the quiz

BPH Quiz
DO YOU HAVE BPH

Get proven BPH relief. Get your first 30-day UROXATRAL prescription for free!
Print the FREE voucher

Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.

Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.

UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.

If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.

Before taking UROXATRAL, tell your doctor if you have kidney problems.

Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.

BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.

The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.

Please see accompanying full prescribing information.

Click here for information on drug anti-counterfeiting.